Merck & Co annual dividends paid
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Merck & Co Dividends Paid Growth & History (MRK)
Merck & Co paid $8.18B in dividends during fiscal 2025.
View full Merck & Co company overviewMerck & Co annual dividends paid history
| Fiscal year | Period ended | Dividends paid | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $8.18B | $336.0M | +4.29% |
| 2024 | 2024-12-31 | $7.84B | $395.0M | +5.31% |
| 2023 | 2023-12-31 | $7.45B | $433.0M | +6.18% |
| 2022 | 2022-12-31 | $7.01B | $402.0M | +6.08% |
| 2021 | 2021-12-31 | $6.61B | $395.0M | +6.36% |
| 2020 | 2020-12-31 | $6.21B | $520.0M | +9.13% |
| 2019 | 2019-12-31 | $5.70B | $523.0M | +10.11% |
| 2018 | 2018-12-31 | $5.17B | $5.0M | +0.10% |
| 2017 | 2017-12-31 | $5.17B | $43.0M | +0.84% |
| 2016 | 2016-12-31 | $5.12B | $7.0M | +0.14% |
| 2015 | 2015-12-31 | $5.12B | −$53.0M | −1.03% |
| 2014 | 2014-12-31 | $5.17B | $13.0M | +0.25% |
| 2013 | 2013-12-31 | $5.16B | $41.0M | +0.80% |
| 2012 | 2012-12-31 | $5.12B | $425.0M | +9.06% |
| 2011 | 2011-12-31 | $4.69B | −$43.0M | −0.91% |
| 2010 | 2010-12-31 | $4.73B | $1.52B | +47.25% |
| 2009 | 2009-12-31 | $3.21B | −$64.0M | −1.95% |
| 2008 | 2008-12-31 | $3.28B | −$28.3M | −0.86% |
| 2007 | 2007-12-31 | $3.31B | — | — |
Merck & Co quarterly dividends paid
Q3.08
Q1.09
Q2.09
Q3.09
Q4.09
Q1.10
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Dividends paid | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.14B | $67.0M | +3.23% |
| Q1 2026 | 2026-03-31 | $2.10B | $55.0M | +2.68% |
| Q4 2025 | 2025-12-31 | $2.02B | $67.0M | +3.43% |
| Q3 2025 | 2025-09-30 | $2.03B | $78.0M | +3.99% |
| Q2 2025 | 2025-06-30 | $2.08B | $91.0M | +4.58% |
| Q1 2025 | 2025-03-31 | $2.05B | $100.0M | +5.13% |
| Q4 2024 | 2024-12-31 | $1.95B | $99.0M | +5.35% |
| Q3 2024 | 2024-09-30 | $1.95B | $98.0M | +5.28% |
| Q2 2024 | 2024-06-30 | $1.99B | $101.0M | +5.36% |
| Q1 2024 | 2024-03-31 | $1.95B | $97.0M | +5.23% |
| Q4 2023 | 2023-12-31 | $1.85B | $102.0M | +5.83% |
| Q3 2023 | 2023-09-30 | $1.85B | $108.0M | +6.18% |
| Q2 2023 | 2023-06-30 | $1.89B | $115.0M | +6.50% |
| Q1 2023 | 2023-03-31 | $1.85B | $108.0M | +6.19% |
| Q4 2022 | 2022-12-31 | $1.75B | $107.0M | +6.51% |
| Q3 2022 | 2022-09-30 | $1.75B | $98.0M | +5.94% |
| Q2 2022 | 2022-06-30 | $1.77B | $97.0M | +5.80% |
| Q1 2022 | 2022-03-31 | $1.75B | $100.0M | +6.08% |
| Q4 2021 | 2021-12-31 | $1.64B | $101.0M | +6.55% |
| Q3 2021 | 2021-09-30 | $1.65B | $104.0M | +6.73% |
| Q2 2021 | 2021-06-30 | $1.67B | $96.0M | +6.09% |
| Q1 2021 | 2021-03-31 | $1.65B | $94.0M | +6.06% |
| Q4 2020 | 2020-12-31 | $1.54B | $137.0M | +9.75% |
| Q3 2020 | 2020-09-30 | $1.54B | $151.0M | +10.83% |
| Q2 2020 | 2020-06-30 | $1.58B | $109.0M | +7.43% |
| Q1 2020 | 2020-03-31 | $1.55B | $123.0M | +8.61% |
| Q4 2019 | 2019-12-31 | $1.41B | $128.0M | +10.02% |
| Q3 2019 | 2019-09-30 | $1.39B | $109.0M | +8.48% |
| Q2 2019 | 2019-06-30 | $1.47B | $157.0M | +11.98% |
| Q1 2019 | 2019-03-31 | $1.43B | $129.0M | +9.93% |
| Q4 2018 | 2018-12-31 | $1.28B | −$6.0M | −0.47% |
| Q3 2018 | 2018-09-30 | $1.28B | $2.0M | +0.16% |
| Q2 2018 | 2018-06-30 | $1.31B | $4.0M | +0.31% |
| Q1 2018 | 2018-03-31 | $1.30B | $5.0M | +0.39% |
| Q4 2017 | 2017-12-31 | $1.28B | $12.0M | +0.94% |
| Q3 2017 | 2017-09-30 | $1.28B | $9.0M | +0.71% |
| Q2 2017 | 2017-06-30 | $1.31B | $7.0M | +0.54% |
| Q1 2017 | 2017-03-31 | $1.29B | $15.0M | +1.17% |
| Q4 2016 | 2016-12-31 | $1.27B | $8.0M | +0.63% |
| Q3 2016 | 2016-09-30 | $1.27B | $2.0M | +0.16% |
| Q2 2016 | 2016-06-30 | $1.30B | −$2.0M | −0.15% |
| Q1 2016 | 2016-03-31 | $1.28B | −$1.0M | −0.08% |
| Q4 2015 | 2015-12-31 | $1.26B | $4.0M | +0.32% |
| Q3 2015 | 2015-09-30 | $1.27B | −$10.0M | −0.78% |
| Q2 2015 | 2015-06-30 | $1.30B | −$37.0M | −2.76% |
| Q1 2015 | 2015-03-31 | $1.28B | −$10.0M | −0.78% |
| Q4 2014 | 2014-12-31 | $1.26B | −$1.0M | −0.08% |
| Q3 2014 | 2014-09-30 | $1.28B | $23.0M | +1.83% |
| Q2 2014 | 2014-06-30 | $1.34B | $7.0M | +0.53% |
| Q1 2014 | 2014-03-31 | $1.29B | −$16.0M | −1.23% |
| Q4 2013 | 2013-12-31 | $1.26B | −$20.0M | −1.56% |
| Q3 2013 | 2013-09-30 | $1.26B | −$18.0M | −1.41% |
| Q2 2013 | 2013-06-30 | $1.33B | $52.0M | +4.06% |
| Q1 2013 | 2013-03-31 | $1.31B | $27.0M | +2.11% |
| Q4 2012 | 2012-12-31 | $1.28B | $115.0M | +9.87% |
| Q3 2012 | 2012-09-30 | $1.28B | $102.0M | +8.68% |
| Q2 2012 | 2012-06-30 | $1.28B | $104.0M | +8.84% |
| Q1 2012 | 2012-03-31 | $1.28B | $104.0M | +8.85% |
| Q4 2011 | 2011-12-31 | $1.17B | −$10.0M | −0.85% |
| Q3 2011 | 2011-09-30 | $1.18B | −$6.0M | −0.51% |
| Q2 2011 | 2011-06-30 | $1.18B | −$13.0M | −1.09% |
| Q1 2011 | 2011-03-31 | $1.18B | −$14.0M | −1.18% |
| Q4 2010 | 2010-12-31 | $1.18B | $370.8M | +46.11% |
| Q3 2010 | 2010-09-30 | $1.18B | $377.1M | +46.91% |
| Q2 2010 | 2010-06-30 | $1.19B | $385.6M | +48.00% |
| Q1 2010 | 2010-03-31 | $1.19B | $385.5M | +47.98% |
| Q4 2009 | 2009-12-31 | $804.2M | — | — |
| Q3 2009 | 2009-09-30 | $803.9M | $697.9M | +658.40% |
| Q2 2009 | 2009-06-30 | $803.4M | — | — |
| Q1 2009 | 2009-03-31 | $803.5M | — | — |
| Q3 2008 | 2008-09-30 | $106.0M | — | — |
Merck & Co dividends paid trends
Over the last five fiscal years, Merck & Co's dividends paid increased from $6.21B to $8.18B, a change of $1.96B. The latest reported quarter, Q2 2026, shows $2.14B.
About the metric
What dividends paid mean
Dividends paid are cash distributions made to shareholders. The history shows the company’s aggregate cash outflow for dividends, not the dividend per share, dividend yield, or the date an investor receives a payment.
Calculation and source
Reported cash dividends paid
TickerStat standardizes cash dividends paid to common or ordinary shareholders from official cash-flow filings. Reported zero-dividend periods remain zero and are not treated as missing data. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Merck & Co source filings ↗